New Drugs FDA Approves Jynarque (tolvaptan) to Slow Kidney Function Decline in Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease 7 years ago
Pharma Industry News FDA advisory committee votes again higher dose of Lilly-Incyte arthritis drug 7 years ago
New Drug Applications Catalyst Pharmaceuticals Announces Submission of New Drug Application for Firdapse for Treatment of Lambert-Eaton Myasthenic Syndrome 7 years ago